Iron-Based Layered Double Hydroxide Implants: Pote... - BV FAPESP
Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Iron-Based Layered Double Hydroxide Implants: Potential Drug Delivery Carriers with Tissue Biointegration Promotion and Blood Microcirculation Preservation

Full text
Author(s):
Figueireclo, Mariana P. [1] ; Cunh, Vanessa R. R. [1] ; Leroux, Fabrice [2] ; Taviot-Gueho, Christine [2] ; Nakamae, Marta N. [3] ; Kang, Ye R. [3] ; Souza, Rodrigo B. [4] ; Martins, Ana Maria C. R. P. F. [5] ; Jun Koh, Ivan Hong [3] ; Constantino, Vera R. L. [1]
Total Authors: 10
Affiliation:
[1] Univ Sao Paulo, Dept Quim Fundamental, Inst Quim, Av Prof Lineu Prestes 748, BR-05508000 Sao Paulo, SP - Brazil
[2] Univ Clermont Auvergne, CNRS, Inst Chim Clermont Ferrand, BP 10448, F-63000 Clermont Ferrand - France
[3] Univ Fed Sao Paulo UNIFESP, Dept Cirurgia, Rua Botucatu 740, BR-04023900 Sao Paulo, SP - Brazil
[4] Univ Fed Sao Paulo UNIFESP, Dept Morfol & Genet, Rua Botucatu 740, BR-04023900 Sao Paulo, SP - Brazil
[5] Secretaria Agr & Abastecimento, Inst Biol, Av Conselheiro Rodrigues Alves 1252, BR-04014002 Sao Paulo, SP - Brazil
Total Affiliations: 5
Document type: Journal article
Source: ACS OMEGA; v. 3, n. 12, p. 18263-18274, DEC 2018.
Web of Science Citations: 0
Abstract

This work explores the synthesis, physicochemical characterization, and in vivo biocompatibility of iron-based layered double hydroxides (LDHs) with molar ratio M2+/(Fe3+ + Al3+) equal to 2, Fe3+/Al3+ equal to 1, and chloride anions as charge-compensating ion (abbreviated Mg4FeAl-Cl and Zn4FeAl-Cl) prepared by the coprecipitation method. The higher structural organization of Zn4FeAl-Cl in comparison to Mg2+ analogous material was noticed by X-ray diffraction and scanning electron microscopy images. Bio-compatibility of LDH was evaluated by intramuscular implantation in rats. Tablets of M4FeAl-Cl (M = Mg, Zn) were readily identified macroscopically after 7 and 28 days of implantation, denoting slow dissolution in the internal medium; adjacent to the tablets, blood flow was preserved without tortuosity or pathological dilatations, according to the Sidestream Dark Field Imaging technique. The histological analysis showed no inflammatory response and the presence of angiogenesis and tissue remodeling with the reconstruction of the extracellular matrix and cells around the tablets, besides the induction of collagen type-I formation. Prussian blue histochemical reaction suggested higher solubility of Mg4FeAl-Cl in the extracellular matrix compared to zinc LDH. Considering the positive biocompatibility results obtained for (M4FeAl)-Fe-II-LDH materials, experiments were conducted to intercalate the anti-inflammatory naproxen, as a model drug, into the iron-based LDHs ((M4FeAl)-Fe-II-NAP). The release profile of NAP in phosphate buffer showed 90% of the drug delivered after about 80 h. However, divalent metal leaching was verified mainly for Mg-LDH (around 50%) when compared to Zn2+ (around 1%). Iron-based LDHs have great potential for medical and technological applications as local drug delivery biomaterials exhibiting biocompatibility and biointegration properties. (AU)

FAPESP's process: 14/15900-0 - Synthesis and characterization of layered double hydroxides consisting of essential metals for drug encapsulation
Grantee:Mariana Pires Figueiredo
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 11/50318-1 - Development of compounds with pharmacological or medicinal interest and of systems for their transport, detection and recognition in biological media
Grantee:Ana Maria da Costa Ferreira
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 16/13862-9 - Conception and development of drug nanocarriers based on layered double hydroxides
Grantee:Mariana Pires Figueiredo
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)
FAPESP's process: 16/50317-9 - Biocompatible nanovectors based on hybrid lamellar materials and composites with polymers for drug release
Grantee:Vera Regina Leopoldo Constantino
Support Opportunities: Regular Research Grants